News

The new Western Memorial Regional Hospital features Canada’s largest geothermal system and the largest solution of its kind for a health care facility in North America. The geothermal field, some 600 ...
Researchers have discovered flower-shaped nanoparticles that restore mitochondrial health, offering hope for new treatments ...
At Texas A&M AgriLife Research, a new branch of brain science is blooming at the molecular scale — with nanoflowers. A study published in The Journal of Biological Chemistry demonstrated that ...
Many people with a Blue Badge may not be aware that they can use the permit to park for free in disabled parking bays in a ...
People with a physical disability or health condition that affects their ability to walk safely, or who have a hidden illness ...
A tiny flower-shaped particle could help to pave the way for a new treatment approach to Alzheimer's and Parkinson's that targets the root causes.
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...
Medical Device Network on MSN15d

Neuralink targets $1bn revenue by 2031

"Neuralink targets $1bn revenue by 2031" was originally created and published by Medical Device Network, a GlobalData owned brand.
In this prescriptive guide, neurologists Dorsey and Okun (Ending Parkinson’s Disease) explain the latest research concerning Parkinson’s, a neurodegenerative disease that causes tremors and ...
the molecular machines responsible for producing most of our cells' energy. These findings suggest a promising new approach to neurotherapeutics that targets the underlying mechanisms of diseases like ...
The next generation of deep-brain stimulation automatically corrects the precise brain waves that create symptoms of Parkinson’s disease. Can this approach target other conditions?